Approval · Notice of Compliance 21814 · 2019
QUEST PLUS GEL: Notice of Compliance 21814
Issued January 31, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21814
- Date
- January 31, 2019
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QUEST PLUS GEL | 02276763 | Marketed |
Medicinal ingredients
- PRAZIQUANTEL 125 MG per ML
- MOXIDECTIN 20 MG per ML